Josh Kleskovic was diagnosed with stage 4 Adenocarcinoma in December of 2024 following nearly a year of appointments and scans to determine the source of his pain and discomfort. He pushed forward with an array of treatments from infusions to chemotherapy for over a year and was working with Boston Gene to have a cancer vaccine developed for his genome when his pain forced his hand in admitting himself to ARHCC for pain management. Weeks of complications led to his passing on February 10th, 2026. He leaves behind a loving wife, two daughters and his dog. This campaign was originally created to raise money for elective cancer treatment but now remains to support the loved ones Josh can no longer be there for.